Sleeping pills for insomnia include prescription medicines such as zolpidem, eszopiclone, ramelteon, doxepin, and dual orexin receptor antagonists, plus over-the-counter sleep aids. For chronic insomnia, cognitive behavioral therapy for insomnia (CBT-I) is usually first-line care; medication may have a role when a clinician finds it appropriate. 1 2
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What are sleeping pills for insomnia?
Sleeping pills, also called sedative-hypnotics, are medicines that can make sleep easier for some people with insomnia. They do not all work the same way: some mainly shorten the time to fall asleep, while others are used for waking during the night. 2
Common prescription groups include benzodiazepine receptor agonists, often called Z-drugs; benzodiazepines; ramelteon, a melatonin receptor agonist; low-dose doxepin; and dual orexin receptor antagonists. The right choice, if medication is used, depends on the sleep pattern, other medicines, age, medical history, and next-day safety needs. 2
When is insomnia considered more than a bad night of sleep?
Chronic insomnia is more than occasional poor sleep. It involves repeated trouble sleeping plus daytime impairment, such as fatigue, irritability, low mood, or trouble concentrating. A clinician looks at the pattern over time and checks for causes that need different care. 1
Sleep-onset insomnia: trouble falling asleep
Sleep-onset insomnia means spending a long time awake before sleep begins. A delayed body-clock schedule, worry about sleep, caffeine, pain, and some medications can contribute. CBT-I can help identify the pattern and reset behaviors that may keep it going. 1
Sleep-maintenance insomnia: waking up or staying awake
Sleep-maintenance insomnia means waking during the night and struggling to return to sleep. It can occur with stress, depression, pain, alcohol use, sleep apnea, restless legs syndrome, or an environment that disrupts sleep. 1
Early-morning awakening and daytime symptoms
Waking much earlier than planned can be part of insomnia, but it can also occur with mood disorders or a shifted circadian rhythm. Daytime impairment matters because it helps distinguish a sleep complaint from a normal short-term change in sleep. 1
Common drivers clinicians look for
A sleep evaluation often considers stress, anxiety, depression, pain, caffeine and alcohol use, medication effects, sleep apnea, and restless legs symptoms. Finding one of these drivers can change the treatment plan because a sleeping pill may not address the underlying problem. 1
What do doctors usually try before or alongside sleeping pills?
CBT-I is usually the best-supported first step for chronic insomnia. It is a structured treatment that works on sleep timing, time awake in bed, unhelpful sleep habits, and the worry that can build around another bad night. 1
Why CBT-I is usually first-line treatment for chronic insomnia
The AASM strongly recommends multicomponent CBT-I for adults with chronic insomnia. It is not simply “sleep hygiene”: it is a targeted behavioral treatment, often delivered in person or online, with techniques selected for the person’s sleep pattern. 1 Learn more about CBT-I treatment and what an online insomnia visit can include in our guide to online treatment for insomnia.
Behavioral therapy and zolpidem: what randomized evidence shows
In a sequential randomized trial of 211 adults with chronic insomnia, both behavioral therapy and zolpidem improved several daytime outcomes. Behavioral therapy had a larger effect on anxiety symptoms, and adding a second treatment helped some people whose insomnia had not remitted after the first stage. Individual results vary, and this trial does not mean one approach fits every person. 3
Sleep habits can support treatment, but they are not a cure for all insomnia
A regular wake time, limiting late caffeine and alcohol, and keeping the bedroom quiet and dark can support treatment. These habits are useful, but persistent insomnia often needs more than a generic checklist, especially when sleep apnea, pain, depression, or medication effects may be involved. 1
Which prescription sleeping pills are used for trouble falling asleep?
For sleep-onset insomnia, clinicians may consider medicines with evidence for helping sleep begin, including zaleplon, zolpidem, eszopiclone, ramelteon, or triazolam. Each has different risks, duration, and interaction concerns. 2
Z-drugs: zolpidem, zaleplon, and eszopiclone
Zolpidem (Ambien), zaleplon (Sonata), and eszopiclone (Lunesta) are benzodiazepine receptor agonists, or Z-drugs. The AASM suggests zaleplon for sleep-onset insomnia and suggests zolpidem and eszopiclone for sleep-onset and sleep-maintenance insomnia when medication is clinically indicated. 2
Melatonin receptor agonist: ramelteon
Ramelteon (Rozerem) acts at melatonin receptors involved in the circadian rhythm, the body’s timing system. It is FDA-approved for sleep-onset insomnia, and the AASM suggests it for that pattern when medication is appropriate. 2 10
Benzodiazepine option: triazolam
Triazolam (Halcion) is a benzodiazepine that the AASM suggests for sleep-onset insomnia when drug therapy is indicated. Benzodiazepines can cause sedation, falls, tolerance, dependence, and withdrawal, so clinicians weigh those risks carefully. 2
Which sleeping pills are used for staying asleep?
For sleep-maintenance insomnia, the goal is often to reduce prolonged wake time after falling asleep without causing unsafe next-day sedation. Options may include a dual orexin receptor antagonist, low-dose doxepin, eszopiclone, zolpidem, or temazepam, depending on the person’s risks. 2
Dual orexin receptor antagonists
Orexin is a brain signaling system that helps promote wakefulness. Dual orexin receptor antagonists, including suvorexant (Belsomra), block orexin signaling and are used for insomnia; the AASM suggests suvorexant for sleep-maintenance insomnia. Daridorexant (Quviviq) is another FDA-approved medicine in this class. 2 8 11
Low-dose doxepin for sleep maintenance
Low-dose doxepin (Silenor) is FDA-approved for insomnia marked by difficulty maintaining sleep. It is different from higher-dose doxepin products used for depression, so a clinician or pharmacist should review the exact product and other medicines. 2 9
Eszopiclone, zolpidem, and temazepam
The AASM suggests eszopiclone, zolpidem, and temazepam for both sleep onset and maintenance when medication is clinically indicated. These medicines can be useful for selected adults, but benefits must be balanced against sedation, falls, driving risk, dependence, and interactions. 2
How do common sleeping pills compare?
Medication choice should follow the sleep problem and safety profile, not a one-size-fits-all ranking. The table below summarizes common options discussed in the AASM guideline and FDA labeling. 2
| Class | Examples | Usually considered for | FDA status for insomnia | Key safety notes |
|---|---|---|---|---|
| Z-drugs | Zolpidem, zaleplon, eszopiclone | Sleep onset; some also for sleep maintenance | FDA-approved products exist | Next-day impairment, falls, dependence risk, and complex sleep behaviors. 2 7 |
| Benzodiazepines | Temazepam, triazolam | Temazepam: onset and maintenance; triazolam: onset | FDA-approved products exist | Tolerance, dependence, withdrawal, falls, and dangerous sedating combinations. 2 |
| Dual orexin receptor antagonists | Suvorexant, daridorexant | Sleep maintenance or mixed insomnia patterns | FDA-approved products exist | Can cause somnolence; review interactions and next-day safety. 8 11 |
| Melatonin receptor agonist | Ramelteon | Sleep onset | FDA-approved | Works through melatonin receptors; not the same as OTC melatonin supplements. 10 |
| Low-dose tricyclic | Doxepin | Sleep maintenance | FDA-approved at low-dose insomnia product strengths | Can cause sedation; exact product and other medicines matter. 9 |
| Sedating antidepressant | Trazodone | Often used off-label | Not FDA-approved for insomnia | AASM suggests clinicians not use trazodone for chronic insomnia because evidence does not support routine use. 2 |
The AASM’s recommendations are mostly weak recommendations, not strong ones. That does not mean the medicines never help; it means the balance of benefit and harm can vary substantially from one person to another, and direct head-to-head comparisons are limited. 2
Are over-the-counter sleep aids effective for insomnia?
OTC sleep aids can cause drowsiness, but “available without a prescription” does not mean risk-free or appropriate for chronic insomnia. The AASM suggests clinicians not use diphenhydramine, melatonin, or valerian for chronic insomnia in adults. 2
Diphenhydramine and doxylamine
Diphenhydramine and doxylamine are sedating antihistamines found in many nonprescription sleep products. They can cause next-day grogginess, confusion, dry mouth, constipation, and urinary problems, and may be especially risky for older adults. 2
Melatonin is a timing signal, not the same as a sedative
Melatonin is a hormone involved in circadian timing. It is not the same as prescription ramelteon, and AASM guidance does not support routine melatonin use for chronic insomnia in adults. 2 10
Valerian and other supplements
Valerian, tryptophan, GABA products, and similar supplements are widely marketed for sleep, but marketing is not the same as reliable evidence. The AASM suggests against valerian and tryptophan for chronic insomnia, and supplements can still interact with medicines. 2
For a fuller review of nonprescription products, see our guide to sleep aids for insomnia. If OTC products become a nightly routine or sleep worsens, it is time for a clinician or pharmacist to review the situation.
What are the main risks of sleeping pills?
The main risks are next-day impairment and unsafe sedation. Depending on the medicine and person, sleep drugs may affect driving, balance, memory, breathing, or alertness the following day. 2 7
- FDA requires a boxed warning for certain insomnia medicines because rare complex sleep behaviors, including sleepwalking and sleep-driving, can lead to serious injury or death. 7
- Benzodiazepines and Z-drugs can lead to tolerance, dependence, withdrawal symptoms, or rebound insomnia when stopped suddenly after regular use. 2
- Alcohol, opioids, benzodiazepines, and other sedating medicines can increase sedation and breathing risk when combined. 7
- Older adults and people with sleep apnea, lung disease, a substance-use history, pregnancy, or fall risk may need added caution or a different approach. 1 2
How should someone talk with a clinician about sleeping pills?
Bring a clear picture of your sleep pattern over time: when the problem started, whether it is falling asleep or staying asleep, what happens during the day, and what you have already tried. This helps a clinician look beyond the medication request and identify treatable drivers. 1
- Share caffeine, alcohol, cannabis, supplements, and all prescription and OTC medicines.
- Mention loud snoring, gasping, leg discomfort at night, depression, anxiety, pain, reflux, or shifts in your work schedule.
- Ask whether CBT-I, a medication, or both make sense for your pattern and medical history.
- Ask about next-day driving, falls, interaction risks, and how medication would be reassessed over time. 1 2
Seek urgent help now for suicidal thoughts, severe depression, dangerous sleep behaviors, confusion after a sleep medicine, severe breathing problems during sleep, or an immediate risk of harming yourself or someone else. In the U.S., call or text 988 for crisis support, or call emergency services for immediate danger. 1 2 7
Does Chia offer sleeping pills for insomnia?
Chia does not currently list prescription sleeping pills or insomnia medication as a public treatment. If insomnia is ongoing, a primary care clinician or sleep-medicine clinician can assess for conditions such as sleep apnea, restless legs syndrome, mood disorders, pain, or medication-related sleep disruption. 1
We do offer educational resources on safe access and evidence-based sleep care, including how to get a sleeping pill prescription safely and sleep-maintenance insomnia treatment. Chia’s weight-management, hormone, and longevity treatments are not insomnia treatments and do not replace a separate evaluation for a persistent sleep problem.
FAQ: sleeping pills for insomnia
Some medicines, including eszopiclone, zolpidem, temazepam, and certain dual orexin receptor antagonists, may be considered for both falling asleep and staying asleep. The best choice depends on your health history, other medicines, and next-day safety needs. 2
Daridorexant is a newer dual orexin receptor antagonist approved in the United States for insomnia. It is one option among several, not automatically the best option for every person. 11
Not necessarily. OTC antihistamine sleep aids can cause next-day drowsiness, confusion, falls, and medication interactions. They are not recommended as routine treatment for chronic insomnia. 2
Some people use an insomnia medicine longer term under close clinician supervision, but nightly use can raise concerns about side effects, dependence, tolerance, and whether the underlying cause is being addressed. Do not change or stop a regular sedative medicine without clinical guidance. 2
Make an appointment when sleep trouble persists, affects daytime functioning, requires frequent use of sleep products, or occurs with snoring or gasping, leg symptoms, depression, anxiety, pain, or medication changes. Seek urgent help for suicidal thoughts, severe breathing problems, or dangerous sleep behaviors. 1 2 7
References
- 1.Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021.
- 2.Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017.
- 3.Morin CM, et al. Effect of Psychological and Medication Therapies for Insomnia on Daytime Function: A Sequential Multiple-Assignment Randomized Clinical Trial. JAMA Psychiatry. 2024.
- 4.Gardner DM, Turner JP, Magalhaes S, et al. Patient Self-Guided Interventions to Reduce Sedative Use and Improve Sleep: The YAWNS NB Randomized Clinical Trial. JAMA Psychiatry. 2024.
- 5.Mak SS, Alessi CA, Kaufmann CN, et al. Pilot RCT Testing a Mailing About Sleeping Pills and Cognitive Behavioral Therapy for Insomnia: Impact on Benzodiazepines and Z-Drugs. Clinical Gerontologist. 2024.
- 6.Chambe J, Reynaud E, Maruani J, et al. Light therapy in insomnia disorder: a systematic review and meta-analysis. Journal of Sleep Research. 2023.
- 7.U.S. Food and Drug Administration. FDA adds Boxed Warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. 2019.
- 8.Merck Sharp & Dohme LLC. Belsomra (suvorexant) prescribing information. U.S. Food and Drug Administration. 2024.
- 9.Currax Pharmaceuticals LLC. Silenor (doxepin) prescribing information. U.S. Food and Drug Administration. 2023.
- 10.Takeda Pharmaceuticals America, Inc. Rozerem (ramelteon) prescribing information. U.S. Food and Drug Administration. 2024.
- 11.Idorsia Pharmaceuticals US Inc. Quviviq (daridorexant) prescribing information. U.S. Food and Drug Administration. 2022.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

